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1. INTRODUCTION {#jocs14186-sec-0050}
===============

Neurological complications represent a fearsome consequence of coronary artery bypass grafting (CABG).[1](#jocs14186-bib-0001){ref-type="ref"}, [2](#jocs14186-bib-0002){ref-type="ref"} Aortic manipulation has been identified as the primary cause of neurological adverse events.[1](#jocs14186-bib-0001){ref-type="ref"}, [2](#jocs14186-bib-0002){ref-type="ref"} Indeed, handling of the aorta can lead to embolus formation and further damage of pre‐existing lesions.[3](#jocs14186-bib-0003){ref-type="ref"} Compared with off‐pump CABG (OPCAB), on‐pump CABG has been shown to be a risk factor for embolization that contributes to an increased number of embolic events.[4](#jocs14186-bib-0004){ref-type="ref"} Hence, the clamp on the aorta and the quality of the perfusion are determinant in the onset of neurological complications.[3](#jocs14186-bib-0003){ref-type="ref"}, [4](#jocs14186-bib-0004){ref-type="ref"}, [5](#jocs14186-bib-0005){ref-type="ref"}

Automated proximal anastomotic devices (APADs) represent a noninvasive and innovative option for the creation of proximal anastomoses.[6](#jocs14186-bib-0006){ref-type="ref"} They can be employed both in traditional CABG and OPCAB. Automated devices in OPCAB do not require an aortic clamp, thus reducing aortic manipulation and, consequently, the potential risk of neurological events.[7](#jocs14186-bib-0007){ref-type="ref"}, [8](#jocs14186-bib-0008){ref-type="ref"}, [9](#jocs14186-bib-0009){ref-type="ref"} This characteristic is critical in the case of the diseased or calcified aorta because the endothelium is not further damaged.[7](#jocs14186-bib-0007){ref-type="ref"}, [8](#jocs14186-bib-0008){ref-type="ref"}, [10](#jocs14186-bib-0010){ref-type="ref"}, [11](#jocs14186-bib-0011){ref-type="ref"} Moreover, APADs have been demonstrated to have optimal results in terms of the patency rate.[12](#jocs14186-bib-0012){ref-type="ref"}, [13](#jocs14186-bib-0013){ref-type="ref"}

Nonetheless, little recent information is available on the follow‐up of APADs, with the majority of studies focused on immediate postoperative results.

Therefore, the aim of our systematic review and metanalysis is to investigate neurological events, graft patency, major adverse cardiovascular events (MACEs), and mortality at 1 year following surgery using APAD and to compare these findings to the current literature.

2. MATERIAL AND METHODS {#jocs14186-sec-0060}
=======================

2.1. Search strategy {#jocs14186-sec-0070}
--------------------

The literature search was performed in conformity with the Preferred Reporting Items for Systematic Review and Meta‐Analyses (PRISMA).[14](#jocs14186-bib-0014){ref-type="ref"} The literature search was conducted by adopting the PubMed and Google Scholar Databases. The search strategy included the use of Boolean logic as well as MeSH terms in the PubMed Database. Further research was performed manually through consultation of the reference lists in the original relevant sources. The search strategy was determined by two authors (FM and OP) and consequently approved by a third reviewer (CT).

Search terms compliant with Boolean logic were "Automatic device" OR "Automatic device proximal anastomoses" AND "Cerebrovascular OR Stroke" AND "Off‐pump"; "Automatic device proximal anastomoses" AND "Cerebrovascular OR Stroke" AND "Off‐pump" AND "CABG". MeSH terms adopted were "Anastomosis, surgical" \[MeSH\] AND "Coronary Artery Bypass, off‐pump/instrumentation" \[Majr\]; "Anastomosis, surgical" \[MeSH\] AND "Coronary Artery Bypass, off‐pump" \[MeSH\] AND "Equipment and supplies" \[MeSH\]; "Anastomosis, surgical/instrumentation" \[MeSH\] AND "Coronary Artery Bypass, off‐pump/instrumentation" \[MeSH\] OR "Coronary Artery Bypass, off‐pump/methods" \[MeSH\]; "Anastomosis, surgical/instrumentation" \[MeSH\] AND "Coronary Artery Bypass/methods" \[MeSH\].

2.2. Selection criteria and quality assessment {#jocs14186-sec-0080}
----------------------------------------------

Studies were selected if the following conditions were met: (a) human studies, (b) articles about automated devices employed for proximal anastomoses, (c) English articles, and (d) articles published in the last 15 years. Exclusion criteria were as follows: (a) animal studies, (b) articles about automated devices employed for distal anastomoses, (c) articles about semiautomated anastomotic devices, (d) case reports, (e) studies including groups of patients with ≤10 individuals, (f) previous reviews and/or metanalyses, (g) articles in languages other than English, and (h) articles published more than 15 years ago.

Two authors (LM and FL) established the inclusion and exclusion criteria. These authors also performed the research on patients' medical histories and results. Two reviewers (MdJ and AM) evaluated the eligibility and the risk of bias of the studies.

2.3. Methodological quality assessment {#jocs14186-sec-0090}
--------------------------------------

The quality of the studies included in the present metanalysis was evaluated by means of the Downs and Black\'s Checklist for Measuring Quality. The aforementioned checklist is composed of 27 items assessing the quality of randomized and nonrandomized studies in terms of reporting, external validity, internal validity, bias, and power. Each component of the checklist is rated on a binary basis (0/1), except two items that are respectively rated on a scale from 0 to 2 or from 0 to 5.[15](#jocs14186-bib-0015){ref-type="ref"} We employed a revised version that includes 18 items, and we established a binary rating of the item related to power. Two researchers (MdJ and AM) were responsible for conducting the ratings, whereas a third party was involved in review (SG). The agreement was quantified by means of Cohen\'s kappa.

2.4. Endpoints {#jocs14186-sec-0100}
--------------

The primary endpoints of our study were the incidence of neurological events, graft patency, MACEs, and mortality of any cause within the first postoperative year.

Neurological events were defined as the onset of global or circumscribed neurological damage occurring immediately after the procedure or later on in patients who initially showed no neurological deficit after awakening.[3](#jocs14186-bib-0003){ref-type="ref"} The neurological complications examined were cerebral anoxia subsequent to transient ischemic attack (TIA) or stroke, as well as delirium and cognitive impairment. We decided to include the latter phenomena because in all of them aortic manipulation can be indicated as an influencing factor.[1](#jocs14186-bib-0001){ref-type="ref"}, [16](#jocs14186-bib-0016){ref-type="ref"}

Graft patency was described as the absence of graft failure due to atherosclerosis, technical complications related to the graft, and intimal hyperplasia resulting from the increased pressure.[17](#jocs14186-bib-0017){ref-type="ref"} Long‐term graft patency influences the prognosis of the CABG procedure.[18](#jocs14186-bib-0018){ref-type="ref"}

We defined MACEs as comprehensive of cardiac death, target vessel revascularization, and myocardial infarction.[19](#jocs14186-bib-0019){ref-type="ref"}

Since cardiac death was included in the definition of MACEs, we decided to examine death from all causes. This decision was dictated by the assumption that analyzing all‐cause death gives less biased outcomes. In fact, bias could result from the classification of the causes of death.[20](#jocs14186-bib-0020){ref-type="ref"}

2.5. Statistical analysis {#jocs14186-sec-0110}
-------------------------

Metanalysis was conducted by means of Comprehensive Meta‐Analysis v.2.2 (Biostat, Englewood, New Jersey). Cumulative incidence and 95% confidence interval (CI) were the main statistical indexes. Heterogeneity of the sources was evaluated by considering the statistical inconsistency test I.[2](#jocs14186-bib-0002){ref-type="ref"}, [21](#jocs14186-bib-0021){ref-type="ref"} Publication bias was mathematically assessed using Egger regression and the Begg‐Mazumdar rank correlation test. Further graphic assessment was applied using a funnel plot and a high‐resolution plot for each of the variables examined. Statistical significance was established for *P* values \< .05.

3. RESULTS {#jocs14186-sec-0120}
==========

3.1. Characteristics of the studies {#jocs14186-sec-0130}
-----------------------------------

The study selection process is represented in the PRISMA flow diagram shown in Figure [1](#jocs14186-fig-0001){ref-type="fig"}. The total number of studies found was 1072. Among these articles, 1029 were excluded either due to a lack of relevance to the topic or inability to access their full texts. At the end of this first selection, 43 were identified as potentially pertinent articles. However, four reviews and metanalyses were eliminated and thus not included in our metanalytic study. Since the focus of our study was to investigate proximal automated anastomotic devices, articles about hand‐sewn anastomotic devices and distal automated anastomotic devices were excluded. Two articles were added from the references of the original sources. As a result, this selection led to the inclusion of nine relevant articles. The selected studies were prospective observational studies encompassing a total of 718 patients.[7](#jocs14186-bib-0007){ref-type="ref"}, [8](#jocs14186-bib-0008){ref-type="ref"}, [9](#jocs14186-bib-0009){ref-type="ref"}, [10](#jocs14186-bib-0010){ref-type="ref"}, [11](#jocs14186-bib-0011){ref-type="ref"}, [12](#jocs14186-bib-0012){ref-type="ref"}, [13](#jocs14186-bib-0013){ref-type="ref"}, [22](#jocs14186-bib-0022){ref-type="ref"}, [23](#jocs14186-bib-0023){ref-type="ref"} Table [1](#jocs14186-tbl-0001){ref-type="table"} shows the characteristics of the study populations included in every study. In addition, a description of the operative data is provided in Table [2](#jocs14186-tbl-0002){ref-type="table"}.

![PRISMA flow diagram of the selection process](JOCS-34-1297-g001){#jocs14186-fig-0001}

###### 

Patients' demographics

                                                                     Female (%)   Age (y) mean ± SD   BMI (kg/m^2^) mean ± SD   Hyperlipidemia (%)   Hypertension (%)   Diabetes (%)   Smoker (%)   Family History of CAD (%)   LVEF (%, mean ± SD)   Prior MI (%)   Prior PCI (%)   Prior CVA (%)
  ------------------------------------------------------------------ ------------ ------------------- ------------------------- -------------------- ------------------ -------------- ------------ --------------------------- --------------------- -------------- --------------- ---------------
  Bassano et al n = 152[8](#jocs14186-bib-0008){ref-type="ref"}      15.8         68.4 ± 9            27.3 ± 3.6                75                   88.1               39.5           23           38.1                        53.2 ± 8.2            27.6           13.8            13.8
  Demertzis et al n = 100[13](#jocs14186-bib-0013){ref-type="ref"}   18           68.9 ± 12           ‐                         66                   94                 45             31                                       57.8 ± 13             44             26              ‐
  Dohmen et al n = 17[10](#jocs14186-bib-0010){ref-type="ref"}       ‐            ‐                   ‐                         ‐                    ‐                  ‐              ‐            ‐                           ‐                     ‐              ‐               ‐
  Puskas et al n = 220[7](#jocs14186-bib-0007){ref-type="ref"}       22.3         68.1 ± 7.3          28.8 ± 4.5                72.7                 85.9               36.8           40.9         ‐                           56.5 ± 12.2           34.5           ‐               6.8
  Kai et al n = 66[12](#jocs14186-bib-0012){ref-type="ref"}          24.2         69.7 ± 10.3         ‐                         51.5                 63.6               37.9           ‐            ‐                           ‐                     34.8           ‐               12.1
  Kempfert et al n = 51[9](#jocs14186-bib-0009){ref-type="ref"}      19.6         74.5 ± 0.6          28 ± 0.5                  84.3                 ‐                  ‐              ‐            ‐                           59.4 ± 2              ‐              ‐               ‐
  Bergmann et al n = 42[22](#jocs14186-bib-0022){ref-type="ref"}     37.5         70.9 ± 7.8          ‐                         33.3                 75                 20.83          ‐            ‐                           63 ± 12.3             33.3           ‐               ‐
  Gummert et al n = 54[11](#jocs14186-bib-0011){ref-type="ref"}      15           69 ± 7              ‐                         81                   ‐                  39             41           ‐                           61 ± 14               ‐              ‐               ‐
  Skjelland et al n = 16[23](#jocs14186-bib-0023){ref-type="ref"}    87.5         ‐                   ‐                         ‐                    ‐                  ‐              ‐            ‐                           ‐                     18.75          ‐               6.25

Abbreviations: BMI, body mass index; CAD, cardiac artery disease; CVA, cerebrovascular accident; LVEF, left ventricle ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention; SD, standard deviation.

John Wiley & Sons, Ltd.

###### 

Operative data

                                                                     Device implanted     On‐pump coronary artery bypass (%)   Off‐pump coronary artery bypass (%)   Grafts (per patient) mean ± SD   Venous graft (%)   Arterial graft (n)
  ------------------------------------------------------------------ -------------------- ------------------------------------ ------------------------------------- -------------------------------- ------------------ --------------------
  Bassano et al n = 152[8](#jocs14186-bib-0008){ref-type="ref"}      Cardica Pas‐Port ®   ‐                                    ‐                                     ‐                                ‐                  ‐
  Demertzis et al n = 100[13](#jocs14186-bib-0013){ref-type="ref"}   Cardica Pas‐Port ®   24                                   76                                    ‐                                ‐                  ‐
  Dohmen et al n = 17[10](#jocs14186-bib-0010){ref-type="ref"}       Cardica Pas‐Port ®   ‐                                    ‐                                     ‐                                ‐                  ‐
  Puskas et al n = 220[7](#jocs14186-bib-0007){ref-type="ref"}       Cardica Pas‐Port ®   36.4                                 63.6                                                                                      
  Kai et al n = 66[12](#jocs14186-bib-0012){ref-type="ref"}          Cardica Pas‐Port ®   4.5                                  95.5                                  ‐                                ‐                  ‐
  Kempfert et al n = 51[9](#jocs14186-bib-0009){ref-type="ref"}      Cardica Pas‐Port ®   7.8                                  92.2                                  ‐                                ‐                  ‐
  Bergmann et al n = 42[22](#jocs14186-bib-0022){ref-type="ref"}     Symmetry             75                                   25                                    ‐                                100                ‐
  Gummert et al n = 54[11](#jocs14186-bib-0011){ref-type="ref"}      Cardica Pas‐Port ®   ‐                                    ‐                                     3.2 ± 0.5                        ‐                  ‐
  Skjelland et al n = 16[23](#jocs14186-bib-0023){ref-type="ref"}    Symmetry             ‐                                    100%                                  ‐                                ‐                  ‐

Abbreviations: SD, standard deviation.

John Wiley & Sons, Ltd.

3.2. Methodological quality {#jocs14186-sec-0140}
---------------------------

The average overall quality rating was 0.81 ± 0.47 with values ranging from 0.39 to 1.56. Appendix 1 presents the average scores on the items of the checklist. The table reveals lower scores for the item assessing whether the studies tested a representative group of the populations. The low values can be attributed to the fact that the characteristics of the samples were not exhaustively determined in each study examined. Furthermore, low scores emerged in relation to the item estimating the appropriateness of data collection. Acceptable interrater agreement was found (κ = 0.63).

3.3. Main endpoints {#jocs14186-sec-0150}
-------------------

The incidence of neurological accidents was considered by six of the selected studies.[7](#jocs14186-bib-0007){ref-type="ref"}, [8](#jocs14186-bib-0008){ref-type="ref"}, [9](#jocs14186-bib-0009){ref-type="ref"}, [11](#jocs14186-bib-0011){ref-type="ref"}, [12](#jocs14186-bib-0012){ref-type="ref"}, [23](#jocs14186-bib-0023){ref-type="ref"} As shown in Figure [2](#jocs14186-fig-0002){ref-type="fig"}A, the cumulative event rate of neurological complications was 4.8% (lower‐upper limits: 2.8‐8.0, *P* \< .001; I^2^ = 72.907%, *P* = .002; Egger\'s test: intercept --2.47, *P = *.16; Begg and Mazumdar test: τ = −0.20, *P = *.57).

![Forest plot event rates of the main endpoints. A, Neurological events. B, Graft patency. C, Major adverse cardiovascular events (MACEs). D, Mortality](JOCS-34-1297-g002){#jocs14186-fig-0002}

Twelve‐month graft patency was assessed by only four of the selected studies.[7](#jocs14186-bib-0007){ref-type="ref"}, [8](#jocs14186-bib-0008){ref-type="ref"}, [9](#jocs14186-bib-0009){ref-type="ref"}, [12](#jocs14186-bib-0012){ref-type="ref"} The cumulative graft patency (Figure [2](#jocs14186-fig-0002){ref-type="fig"}B) was 90.5% (80.4‐95.7, *P* \< .001; I^2^ = 76.823%, *P* = .005; Egger\'s test: intercept --3.04, *P = *.10; Begg and Mazumdar test: τ = −0.67, *P = *.17).

Furthermore, four papers reported MACEs.[7](#jocs14186-bib-0007){ref-type="ref"}, [9](#jocs14186-bib-0009){ref-type="ref"}, [11](#jocs14186-bib-0011){ref-type="ref"}, [12](#jocs14186-bib-0012){ref-type="ref"} The overall incidence of MACE (Figure [2](#jocs14186-fig-0002){ref-type="fig"}C) was 3.7% (1.3‐10.4, *P* \< .001; I^2^ = 51.556%, *P* = .103; Egger\'s test: intercept --1.98, *P = *.11; Begg and Mazumdar test: τ = −0.67, *P = *.17).

Finally, mortality within 1 year was described by seven of the selected studies.[7](#jocs14186-bib-0007){ref-type="ref"}, [8](#jocs14186-bib-0008){ref-type="ref"}, [9](#jocs14186-bib-0009){ref-type="ref"}, [11](#jocs14186-bib-0011){ref-type="ref"}, [12](#jocs14186-bib-0012){ref-type="ref"}, [13](#jocs14186-bib-0013){ref-type="ref"}, [23](#jocs14186-bib-0023){ref-type="ref"} The overall incidence of mortality (Figure [2](#jocs14186-fig-0002){ref-type="fig"}C) was 5% (3.5‐7, *P* \< .001; I^2^ = 29.675%, *P* = .202; Egger\'s test: intercept --0.91, *P = *.62; Begg and Mazumdar test: τ = −0.04, *P = *.88).

4. DISCUSSION {#jocs14186-sec-0160}
=============

Because of the paucity of information related to automated proximal anastomotic devices (APADs), this review and metanalysis was aimed at examining the incidence of neurological events, graft patency, MACEs, and mortality within 1 year from surgery employing these devices, which is the longest common follow‐up time in studies on the topic.

APADs were introduced in clinical practice to reduce the incidence of neurological complications. The manipulation of the aorta represents a well‐known and consistent risk factor for the development of perioperative and postoperative stroke, both in the short‐ and long‐term.[3](#jocs14186-bib-0003){ref-type="ref"}, [5](#jocs14186-bib-0005){ref-type="ref"} Manipulating the aorta can cause the embolization of pre‐existing atheromatic lesions in the vessel and contributes to the formation of thrombi and emboli, whose nature can be gaseous or solid.[3](#jocs14186-bib-0003){ref-type="ref"}, [24](#jocs14186-bib-0024){ref-type="ref"} These phenomena are associated with the placement of the clamp on the aorta as well as its removal, because debris belonging to the atheroma can be dislocated.[25](#jocs14186-bib-0025){ref-type="ref"} Indeed, Eldaif et al[24](#jocs14186-bib-0024){ref-type="ref"} reported that 79% of the emboli detected in their study originated at the removal of the aortic clamp. The incidence of cerebrovascular accidents is correlated with the presence of extensive atherosclerotic disease that is not merely circumscribed to the coronaries and the aorta.[3](#jocs14186-bib-0003){ref-type="ref"} For this reason, Nakamura et al[26](#jocs14186-bib-0026){ref-type="ref"} underline the importance of accurate preoperative screening. Matsuura et al[27](#jocs14186-bib-0027){ref-type="ref"} note the importance of not touching the aorta for reducing the risk of stroke. Furthermore, avoiding manipulation of the aorta is critical in patients with "porcelain" aorta, since the risk of causing the mobilization of atheromatous material is higher in these patients.[10](#jocs14186-bib-0010){ref-type="ref"} Hence, creating anastomoses with the use of APADs should theoretically reduce the risk of stroke and neurological complications.[8](#jocs14186-bib-0008){ref-type="ref"} However, the creation of proximal anastomoses itself can be responsible for embolus formation.[2](#jocs14186-bib-0002){ref-type="ref"}

The selected papers used two types of such devices: the St Jude Symmetry (St Jude Medical, Inc, Minneapolis, MN) and the Cardica PAS‐Port (Cardica, Inc., Redwood City, CA).[6](#jocs14186-bib-0006){ref-type="ref"} Studies of the Symmetry device have shown poor results in terms of graft patency and number of emboli, which compromise patient safety.[6](#jocs14186-bib-0006){ref-type="ref"}, [23](#jocs14186-bib-0023){ref-type="ref"} As a consequence, the device has been withdrawn from the market.[6](#jocs14186-bib-0006){ref-type="ref"}, [7](#jocs14186-bib-0007){ref-type="ref"} Indeed, Skjelland et al[23](#jocs14186-bib-0023){ref-type="ref"} observed a significant growth in the number of emboli, both solid and gaseous, in the group of patients treated with the Symmetry connector device. The phenomenon of solid embolus formation is related to the perforation of atheromatous material during insertion of the device. The creation of gaseous emboli might be caused by the inflation of air coming from the device itself during its attachment or by the shift in aortic diameter following the introduction of the device.[23](#jocs14186-bib-0023){ref-type="ref"} By contrast, the employment of the PAS‐Port device has given acceptable results. In fact, some studies claim a reduction in the frequency of cerebrovascular accidents by adopting the PAS‐Port device.[3](#jocs14186-bib-0003){ref-type="ref"}, [8](#jocs14186-bib-0008){ref-type="ref"}, [9](#jocs14186-bib-0009){ref-type="ref"} This might depend upon the speed of implantation and involvement of the minimal aortic area during the procedure. These characteristics are crucial in the presence of severe calcification or atherosclerosis of the aortic vessel.[8](#jocs14186-bib-0008){ref-type="ref"}, [28](#jocs14186-bib-0028){ref-type="ref"}

The main finding of our study is the not‐negligible overall incidence of neurological events, which was 4.8% (2.8‐8.0) evaluated on 559 patients.[7](#jocs14186-bib-0007){ref-type="ref"}, [8](#jocs14186-bib-0008){ref-type="ref"}, [9](#jocs14186-bib-0009){ref-type="ref"}, [11](#jocs14186-bib-0011){ref-type="ref"}, [12](#jocs14186-bib-0012){ref-type="ref"}, [23](#jocs14186-bib-0023){ref-type="ref"} This is in contrast with the lower rates reported in the literature. Indeed, Misfeld et al[29](#jocs14186-bib-0029){ref-type="ref"} showed an incidence of 0.5% for a cohort of 5619 patients in terms of neurological events using the off‐pump "anaortic" approach to coronary artery bypass grafting (OPCAB). For traditional on‐pump coronary artery bypass grafting (CABG) with a cross‐clamp, Calafiore et al[3](#jocs14186-bib-0003){ref-type="ref"} described an incidence of cerebrovascular events of 1.2% for 2233 patients. The SYNTAX Trial identified an incidence of stroke of 2.3% in 897 individuals.[30](#jocs14186-bib-0030){ref-type="ref"} However, our results were strongly influenced by the findings of Kempfert et al,[9](#jocs14186-bib-0009){ref-type="ref"} who described six episodes of postoperative delirium in six different patients and one episode of fatal stroke within the first year, reaching a total event rate of 13.7% in 51 subjects.

Second, we showed that the overall event rate of graft patency was 90.5%.[7](#jocs14186-bib-0007){ref-type="ref"}, [8](#jocs14186-bib-0008){ref-type="ref"}, [9](#jocs14186-bib-0009){ref-type="ref"}, [12](#jocs14186-bib-0012){ref-type="ref"} This figure is inferior compared with the pure "anaortic" technique. Actually, Halbersma et al[30](#jocs14186-bib-0030){ref-type="ref"} found that 99.2% of grafts were patent after OPCAB performed with the no‐touch technique. However, our figure compares favorably to the results from PREVENT IV, which reports a one‐year venous graft patency of 58.3% in a cohort of 951 patients[31](#jocs14186-bib-0031){ref-type="ref"} after traditional CABG surgery. The graft patency reported in our study is strongly influenced by the poor performance of the Symmetry device. Bergmann et al[22](#jocs14186-bib-0022){ref-type="ref"} reported stenoses in the proximity of device implantation, thus suggesting its involvement in the process. Histopathological evidence seems to confirm the endothelial damage caused by the device, as well as dissection of the tunica media in some cases.[32](#jocs14186-bib-0032){ref-type="ref"} Puskas et al[7](#jocs14186-bib-0007){ref-type="ref"} attributed these changes to endothelial damage because of the quantity of external material implanted.

Third, from our metanalysis emerged the superiority of anastomotic devices in reducing the occurrence of MACEs. Indeed, we found an incidence of 3.7% in a group of 391 patients,[7](#jocs14186-bib-0007){ref-type="ref"}, [9](#jocs14186-bib-0009){ref-type="ref"}, [11](#jocs14186-bib-0011){ref-type="ref"}, [12](#jocs14186-bib-0012){ref-type="ref"} which compares favorably to the current literature. Indeed, PREVENT IV reported an incidence of MACEs of 8.1% among 1506 patients undergoing traditional on‐pump CABG.[31](#jocs14186-bib-0031){ref-type="ref"} Furthermore, SYNTAX published a rate of MACEs of 12.4% in 897 patients. The frequency reported in our paper is also inferior to the off‐pump "anaortic" approach, which was associated with a prevalence of MACEs of 5.3% in a group of 400 patients.[30](#jocs14186-bib-0030){ref-type="ref"}

Finally, the incidence of death at 1 year was 5% in a group of 659 patients.[7](#jocs14186-bib-0007){ref-type="ref"}, [8](#jocs14186-bib-0008){ref-type="ref"}, [9](#jocs14186-bib-0009){ref-type="ref"}, [11](#jocs14186-bib-0011){ref-type="ref"}, [12](#jocs14186-bib-0012){ref-type="ref"}, [13](#jocs14186-bib-0013){ref-type="ref"}, [23](#jocs14186-bib-0023){ref-type="ref"} This compares unfavorably to both no‐touch OPCAB and traditional CABG. In fact, the SYNTAX trial evaluating traditional CABG established an event rate of 3.5% in 897 patients.[30](#jocs14186-bib-0030){ref-type="ref"} In off‐pump no‐touch procedures, Halbersma et al[30](#jocs14186-bib-0030){ref-type="ref"} showed that in a pool of 400 patients, the frequency of all‐cause mortality was 1.8%.

5. LIMITATIONS {#jocs14186-sec-0170}
==============

This metanalysis has five main limitations that must be pointed out. First, the sample size is small, and high heterogeneity was detected. However, the heterogeneity was addressed by employing a random model. Second, the potential bias due to the small sample does not allow us to draw final conclusions. Third, we could not compare results with conventional surgery given the limited number of cases analyzed. Fourth, the four main endpoints were not always reported in the studies examined. Finally, delirium and cognitive impairment may be underestimated since only one paper referred to a systematic neurocognitive test.

6. CONCLUSIONS {#jocs14186-sec-0180}
==============

In conclusion, APADs do not seem to be correlated to a reduction of either neurological events or mortality. By contrast, these tools showed satisfactory one‐year graft patency and a low incidence of MACEs. Further research on this topic is warranted.
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 {#jocs14186-sec-0220}

ItemMSD1Study hypothesis/aim/objective described?0.890.322Main outcomes described in the introduction or methods?0.610.503Participant characteristics described?0.890.324Contacted participants representative?0.560.515Prepared participants representative?0.440.516Participants recruited from the same population?0.670.497Participants recruited over the same time?0.780.438Measures and experimental tasks described?1.000.009Main outcome measures valid and reliable?0.940.2410Task engagement assessed?0.780.4311Confounders described and controlled for?1.560.5112Statistical tests appropriate?0.940.2413Main findings described?1.000.0014Estimates of the random variability in data main outcomes?0.890.3215Probability values reported?0.670.4916Withdrawals and drop‐outs reported?0.890.3217Data dredging made clear?0.390.5018Sufficient power analysis provided?0.670.49[^1]John Wiley & Sons, Ltd.

[^1]: *Notes*: All items have a maximum score of 1.00 except for item 11, which has a maximum score of 2.00.
